CLINICAL_TRIALS
trial_result
· 2019-06-12
Clinical Trial Update: Secukinumab for Treatment of Atopic Dermatitis [Phase 2]
Summary
Phase 2 trial evaluating secukinumab for atopic dermatitis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2019-06-12